The relationship between ApoE4 and C/EBP in Alzheimer's disease
ApoE4 and C/EBP: Mutually Regulate Each Other in Alzheimer's Disease
This study is looking at how a gene linked to Alzheimer's disease interacts with a protein that affects inflammation and aging, to help us understand more about the disease and find better ways to treat or prevent it for people at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10816974 on NIH RePORTER |
What this research studies
This research investigates how the ApoE4 gene, a major risk factor for Alzheimer's disease, interacts with a protein called C/EBPβ, which is involved in inflammation and aging. The study focuses on understanding how these two factors influence each other and contribute to the development of Alzheimer's disease. By examining their roles in the brain, particularly in glial cells and neurons, the research aims to uncover new insights into the mechanisms of Alzheimer's and potential therapeutic targets. Patients may benefit from findings that could lead to improved treatments or preventive strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those with the ApoE4 allele.
Not a fit: Patients without any genetic predisposition to Alzheimer's disease or those with advanced Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that slow down or prevent the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the roles of ApoE and related pathways in Alzheimer's disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Benian, Guy Martin — Emory University
- Study coordinator: Benian, Guy Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.